Cargando…

The Molecular Mechanism of Herpes Simplex Virus 1 UL31 in Antagonizing the Activity of IFN-β

Virus infection triggers intricate signal cascade reactions to activate the host innate immunity, which leads to the production of type I interferon (IFN-I). Herpes simplex virus 1 (HSV-1), a human-restricted pathogen, is capable of encoding over 80 viral proteins, and several of them are involved i...

Descripción completa

Detalles Bibliográficos
Autores principales: Gong, Lan, Ou, Xiaowen, Hu, Li, Zhong, Jiayi, Li, Jingjing, Deng, Shenyu, Li, Bolin, Pan, Lingxia, Wang, Liding, Hong, Xuejun, Luo, Wenqi, Zeng, Qiyuan, Zan, Jie, Peng, Tao, Cai, Mingsheng, Li, Meili
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Microbiology 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8865407/
https://www.ncbi.nlm.nih.gov/pubmed/35196784
http://dx.doi.org/10.1128/spectrum.01883-21
_version_ 1784655630582153216
author Gong, Lan
Ou, Xiaowen
Hu, Li
Zhong, Jiayi
Li, Jingjing
Deng, Shenyu
Li, Bolin
Pan, Lingxia
Wang, Liding
Hong, Xuejun
Luo, Wenqi
Zeng, Qiyuan
Zan, Jie
Peng, Tao
Cai, Mingsheng
Li, Meili
author_facet Gong, Lan
Ou, Xiaowen
Hu, Li
Zhong, Jiayi
Li, Jingjing
Deng, Shenyu
Li, Bolin
Pan, Lingxia
Wang, Liding
Hong, Xuejun
Luo, Wenqi
Zeng, Qiyuan
Zan, Jie
Peng, Tao
Cai, Mingsheng
Li, Meili
author_sort Gong, Lan
collection PubMed
description Virus infection triggers intricate signal cascade reactions to activate the host innate immunity, which leads to the production of type I interferon (IFN-I). Herpes simplex virus 1 (HSV-1), a human-restricted pathogen, is capable of encoding over 80 viral proteins, and several of them are involved in immune evasion to resist the host antiviral response through the IFN-I signaling pathway. Here, we determined that HSV-1 UL31, which is associated with nuclear matrix and is essential for the formation of viral nuclear egress complex, could inhibit retinoic acid-inducible gene I (RIG-I)-like receptor pathway-mediated interferon beta (IFN-β)–luciferase (Luc) and (PRDIII-I)4-Luc (an expression plasmid of IFN-β positive regulatory elements III and I) promoter activation, as well as the mRNA transcription of IFN-β and downstream interferon-stimulated genes (ISGs), such as ISG15, ISG54, ISG56, etc., to promote viral infection. UL31 was shown to restrain IFN-β activation at the interferon regulatory factor 3 (IRF3)/IRF7 level. Mechanically, UL31 was demonstrated to interact with TANK binding kinase 1 (TBK1), inducible IκB kinase (IKKi), and IRF3 to impede the formation of the IKKi-IRF3 complex but not the formation of the IRF7-related complex. UL31 could constrain the dimerization and nuclear translocation of IRF3. Although UL31 was associated with the CREB binding protein (CBP)/p300 coactivators, it could not efficiently hamper the formation of the CBP/p300-IRF3 complex. In addition, UL31 could facilitate the degradation of IKKi and IRF3 by mediating their K48-linked polyubiquitination. Taken together, these results illustrated that UL31 was able to suppress IFN-β activity by inhibiting the activation of IKKi and IRF3, which may contribute to the knowledge of a new immune evasion mechanism during HSV-1 infection. IMPORTANCE The innate immune system is the first line of host defense against the invasion of pathogens. Among its mechanisms, IFN-I is an essential cytokine in the antiviral response, which can help the host eliminate a virus. HSV-1 is a double-stranded DNA virus that can cause herpes and establish a lifelong latent infection, due to its possession of multiple mechanisms to escape host innate immunity. In this study, we illustrate for the first time that the HSV-1-encoded UL31 protein has a negative regulatory effect on IFN-β production by blocking the dimerization and nuclear translocation of IRF3, as well as promoting the K48-linked polyubiquitination and degradation of both IKKi and IRF3. This study may be helpful for fully understanding the pathogenesis of HSV-1.
format Online
Article
Text
id pubmed-8865407
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher American Society for Microbiology
record_format MEDLINE/PubMed
spelling pubmed-88654072022-03-02 The Molecular Mechanism of Herpes Simplex Virus 1 UL31 in Antagonizing the Activity of IFN-β Gong, Lan Ou, Xiaowen Hu, Li Zhong, Jiayi Li, Jingjing Deng, Shenyu Li, Bolin Pan, Lingxia Wang, Liding Hong, Xuejun Luo, Wenqi Zeng, Qiyuan Zan, Jie Peng, Tao Cai, Mingsheng Li, Meili Microbiol Spectr Research Article Virus infection triggers intricate signal cascade reactions to activate the host innate immunity, which leads to the production of type I interferon (IFN-I). Herpes simplex virus 1 (HSV-1), a human-restricted pathogen, is capable of encoding over 80 viral proteins, and several of them are involved in immune evasion to resist the host antiviral response through the IFN-I signaling pathway. Here, we determined that HSV-1 UL31, which is associated with nuclear matrix and is essential for the formation of viral nuclear egress complex, could inhibit retinoic acid-inducible gene I (RIG-I)-like receptor pathway-mediated interferon beta (IFN-β)–luciferase (Luc) and (PRDIII-I)4-Luc (an expression plasmid of IFN-β positive regulatory elements III and I) promoter activation, as well as the mRNA transcription of IFN-β and downstream interferon-stimulated genes (ISGs), such as ISG15, ISG54, ISG56, etc., to promote viral infection. UL31 was shown to restrain IFN-β activation at the interferon regulatory factor 3 (IRF3)/IRF7 level. Mechanically, UL31 was demonstrated to interact with TANK binding kinase 1 (TBK1), inducible IκB kinase (IKKi), and IRF3 to impede the formation of the IKKi-IRF3 complex but not the formation of the IRF7-related complex. UL31 could constrain the dimerization and nuclear translocation of IRF3. Although UL31 was associated with the CREB binding protein (CBP)/p300 coactivators, it could not efficiently hamper the formation of the CBP/p300-IRF3 complex. In addition, UL31 could facilitate the degradation of IKKi and IRF3 by mediating their K48-linked polyubiquitination. Taken together, these results illustrated that UL31 was able to suppress IFN-β activity by inhibiting the activation of IKKi and IRF3, which may contribute to the knowledge of a new immune evasion mechanism during HSV-1 infection. IMPORTANCE The innate immune system is the first line of host defense against the invasion of pathogens. Among its mechanisms, IFN-I is an essential cytokine in the antiviral response, which can help the host eliminate a virus. HSV-1 is a double-stranded DNA virus that can cause herpes and establish a lifelong latent infection, due to its possession of multiple mechanisms to escape host innate immunity. In this study, we illustrate for the first time that the HSV-1-encoded UL31 protein has a negative regulatory effect on IFN-β production by blocking the dimerization and nuclear translocation of IRF3, as well as promoting the K48-linked polyubiquitination and degradation of both IKKi and IRF3. This study may be helpful for fully understanding the pathogenesis of HSV-1. American Society for Microbiology 2022-02-23 /pmc/articles/PMC8865407/ /pubmed/35196784 http://dx.doi.org/10.1128/spectrum.01883-21 Text en Copyright © 2022 Gong et al. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution 4.0 International license (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Research Article
Gong, Lan
Ou, Xiaowen
Hu, Li
Zhong, Jiayi
Li, Jingjing
Deng, Shenyu
Li, Bolin
Pan, Lingxia
Wang, Liding
Hong, Xuejun
Luo, Wenqi
Zeng, Qiyuan
Zan, Jie
Peng, Tao
Cai, Mingsheng
Li, Meili
The Molecular Mechanism of Herpes Simplex Virus 1 UL31 in Antagonizing the Activity of IFN-β
title The Molecular Mechanism of Herpes Simplex Virus 1 UL31 in Antagonizing the Activity of IFN-β
title_full The Molecular Mechanism of Herpes Simplex Virus 1 UL31 in Antagonizing the Activity of IFN-β
title_fullStr The Molecular Mechanism of Herpes Simplex Virus 1 UL31 in Antagonizing the Activity of IFN-β
title_full_unstemmed The Molecular Mechanism of Herpes Simplex Virus 1 UL31 in Antagonizing the Activity of IFN-β
title_short The Molecular Mechanism of Herpes Simplex Virus 1 UL31 in Antagonizing the Activity of IFN-β
title_sort molecular mechanism of herpes simplex virus 1 ul31 in antagonizing the activity of ifn-β
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8865407/
https://www.ncbi.nlm.nih.gov/pubmed/35196784
http://dx.doi.org/10.1128/spectrum.01883-21
work_keys_str_mv AT gonglan themolecularmechanismofherpessimplexvirus1ul31inantagonizingtheactivityofifnb
AT ouxiaowen themolecularmechanismofherpessimplexvirus1ul31inantagonizingtheactivityofifnb
AT huli themolecularmechanismofherpessimplexvirus1ul31inantagonizingtheactivityofifnb
AT zhongjiayi themolecularmechanismofherpessimplexvirus1ul31inantagonizingtheactivityofifnb
AT lijingjing themolecularmechanismofherpessimplexvirus1ul31inantagonizingtheactivityofifnb
AT dengshenyu themolecularmechanismofherpessimplexvirus1ul31inantagonizingtheactivityofifnb
AT libolin themolecularmechanismofherpessimplexvirus1ul31inantagonizingtheactivityofifnb
AT panlingxia themolecularmechanismofherpessimplexvirus1ul31inantagonizingtheactivityofifnb
AT wangliding themolecularmechanismofherpessimplexvirus1ul31inantagonizingtheactivityofifnb
AT hongxuejun themolecularmechanismofherpessimplexvirus1ul31inantagonizingtheactivityofifnb
AT luowenqi themolecularmechanismofherpessimplexvirus1ul31inantagonizingtheactivityofifnb
AT zengqiyuan themolecularmechanismofherpessimplexvirus1ul31inantagonizingtheactivityofifnb
AT zanjie themolecularmechanismofherpessimplexvirus1ul31inantagonizingtheactivityofifnb
AT pengtao themolecularmechanismofherpessimplexvirus1ul31inantagonizingtheactivityofifnb
AT caimingsheng themolecularmechanismofherpessimplexvirus1ul31inantagonizingtheactivityofifnb
AT limeili themolecularmechanismofherpessimplexvirus1ul31inantagonizingtheactivityofifnb
AT gonglan molecularmechanismofherpessimplexvirus1ul31inantagonizingtheactivityofifnb
AT ouxiaowen molecularmechanismofherpessimplexvirus1ul31inantagonizingtheactivityofifnb
AT huli molecularmechanismofherpessimplexvirus1ul31inantagonizingtheactivityofifnb
AT zhongjiayi molecularmechanismofherpessimplexvirus1ul31inantagonizingtheactivityofifnb
AT lijingjing molecularmechanismofherpessimplexvirus1ul31inantagonizingtheactivityofifnb
AT dengshenyu molecularmechanismofherpessimplexvirus1ul31inantagonizingtheactivityofifnb
AT libolin molecularmechanismofherpessimplexvirus1ul31inantagonizingtheactivityofifnb
AT panlingxia molecularmechanismofherpessimplexvirus1ul31inantagonizingtheactivityofifnb
AT wangliding molecularmechanismofherpessimplexvirus1ul31inantagonizingtheactivityofifnb
AT hongxuejun molecularmechanismofherpessimplexvirus1ul31inantagonizingtheactivityofifnb
AT luowenqi molecularmechanismofherpessimplexvirus1ul31inantagonizingtheactivityofifnb
AT zengqiyuan molecularmechanismofherpessimplexvirus1ul31inantagonizingtheactivityofifnb
AT zanjie molecularmechanismofherpessimplexvirus1ul31inantagonizingtheactivityofifnb
AT pengtao molecularmechanismofherpessimplexvirus1ul31inantagonizingtheactivityofifnb
AT caimingsheng molecularmechanismofherpessimplexvirus1ul31inantagonizingtheactivityofifnb
AT limeili molecularmechanismofherpessimplexvirus1ul31inantagonizingtheactivityofifnb